La re-resección transuretral puede no ser necesaria en todos los tumores vesicales no músculo-invasivos de alto grado
Author:
Publisher
Elsevier BV
Subject
Urology
Reference30 articles.
1. Bladder cancer: epidemiology, staging and grading, and diagnosis;Kirkali;Urology,2005
2. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
3. Multivariate analysis of the prognostic factors of primary superficial bladder cancer;Millán-Rodríguez;J Urol,2000
4. Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives;Babjuk;Euro Urol,2010
5. The value of a second transurethral resection in evaluating patients with bladder tumours;Miladi;Eur Urol,2003
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guérin: Implications for Risk-adapted Follow-up;European Urology Focus;2023-03
2. Department of Surgery, Autonomous University of Barcelona, Barcelona, Spain br;EUR UROL ONCOL;2022
3. En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial;European Urology Oncology;2022-08
4. Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: Lessons learned from long-term follow-up of a series of CIS patients treated with BCG;Urologic Oncology: Seminars and Original Investigations;2022-01
5. Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette–Guérin immunotherapy;BJU International;2021-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3